Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Virology Journal Année : 2018

Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

Résumé

Here we propose a strategy allowing implementing efficient and practicable large-scale seroepidemiological studies for Zika Virus (ZIKV). It combines screening by a commercial NS1 protein-based Zika IgG ELISA, and confirmation by a cytopathic effect-based virus neutralization test (CPE-based VNT). In post-epidemic samples from Martinique Island blood donors (a population with a dengue seroprevalence above 90%), this strategy allowed reaching specificity and sensitivity values over 98%. The CPE-based VNT consists of recording CPE directly under the optical microscope, which is easy to identify with ZIKV strain H/PF/2013 at day 5 pi. Overall, considered that CPE-based VNT is cost effective and widely automatable, the NS1 protein-based Zika IgG ELISA+CPE-based VNT combination strategy represents a convenient tool to expedite ZIKV seroprevalence studies.
Fichier principal
Vignette du fichier
document(19).pdf (689.64 Ko) Télécharger le fichier
document(20).pdf (138.47 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-02044109 , version 1 (08-03-2019)

Licence

Paternité

Identifiants

Citer

Elif Nurtop, Paola Mariela Saba Villarroel, Boris Pastorino, Laetitia Ninove, Jan Felix Drexler, et al.. Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies. Virology Journal, 2018, 15 (1), pp.192. ⟨10.1186/s12985-018-1105-5⟩. ⟨hal-02044109⟩
138 Consultations
139 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More